level-one heading

Kolabtreeを選ぶ理由
開始はすばやく簡単です。初期費用はかかりません。
サービス依頼と専門家への見積依頼は無料です。
Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。
専門家と直接連携し、必要な成果を正しく得られます。
専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。
この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
プロジェクトを作成
★★★★★
☆☆☆☆☆
Dr. Pari J.に依頼
Australia

Medical Advisor/Clinical Research professional with PhD and 10+ years of global experience in Healthcare Industry

プロフィール概要
専門分野
サービス
Writing Technical Writing
Research Market Research, Feasibility Study, Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection
Product Development Formulation
職務経験

Medical affairs and Clinical Science Professional/Medical Science Liaison

Medtronic

1月 2018 - 8月 2020

Clinical Study Start-up Specialist

IQVIA

9月 2017 - 12月 2017

Clinical Start-up and Regulatory Specialist (Medical writer/Medical Communication)

Syneos Health (Previously INCResearch)

9月 2015 - 8月 2017

Clinical Research Professional (Study Manager for Pharmaceutical trials)

PRA Health Sciences

5月 2013 - 9月 2015

Medical Science Liaison

Illawarra Health and Medical Research Institute

5月 2011 - 5月 2013

Research Scientist

Wollongong University

1月 2007 - 6月 2012

Senior Clinical Science Associate

Health Management and Economic Research Center - Isfahan University

9月 2004 - 9月 2006

学歴

PhD - Pharmacology

Wollongong University

1月 2009 - 6月 2012

Master of Science in Medicinal and Pharmaceutical Chemistry - Research

Wollongong University

1月 2007 - 11月 2008

University of Isfahan

Bachelor of Chemistry

10月 2000 - 6月 2004

認定資格
  • 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
(2006). Mathematical model for determination of colloid osmotic pressure: The role of albumin-globulin ratio. Journal of Research in Medical Science. Journal of Research in Medical Science.
CONFERENCE PAPER
(2012). Development of novel antipsychotic drugs with lower obesogenic effects. The 32nd Annual Meeting of The Australian Neuroscience Society.
CONFERENCE ABSTRACT
(2011). Development of novel antipsychotic drugs based on olanzapine that display reduced weight gain and metabolic side effects. 24th European Congress of Neuropsychopharmacology.
(2011). In vivo pharmacological evaluation of novel olanzapine analogues in rat: Potential novel antipsychotic drugs with lower obesogenic effect. 3rd European Conference on Schizophrenia Research.